French Version of Fear-Avoidance Component Scale (FACS-FR)
CompletedNot applicableNCT05217017
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
Chronic musculoskeletal disorders are global burden for economy. Fear-avoidance (FA) seems be a predictor for the transition from subacute to chronic pain. One of the most famous scales to access FA is the Tampa scale of kinesiophobia, but several responders think some items are not clear, too narrow or too general. A new scale, the Fear-Avoidance Components Scale (FACS) was developed by Neblett et al. in 2015 to assess FA. It is a comprehensive set of concepts that more effectively addresses all the essential issues of the FA concept than the current scales. The new scale comprehensively assesses all cognitive, emotional, and behavioral components related to the updated FA model by combining items from well-known scales in the context of the FA model with items on perceived injury-related victimization and blame. A French version of the FACS is currently lacking. The aim of this study is to provide a translation and validation of a French version of FACS in patients with musculoskeletal disorders.
Study details
- Official title
- Psychometric Validation of the French Version of the Fear Avoidance Component Scale (FACS)
- Conditions
- Interventions
- Diagnostic test: FACS
- Sponsor
- Université de Sherbrooke
- Start date
- 2022-02-01
- Primary completion
- 2023-02-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * At least 18 years old * Current chronic pain complaint is not surgically treated (at least 6 weeks of pain) * Not being currently treated by a physiotherapist for pain complaint * French language is mother tongue Exclusion Criteria: * Pain from a non-musculoskeletal origin (e.g., tumour) * Neurological disease * Impaired cognition
Canadian sites (1)
| Facility | City | Province |
|---|---|---|
| Centre de recherche du CHUS (CRCHUS) | Sherbrooke | Quebec |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05217017